DISEASE INDICATIONS: Cystic Fibrosis

MANUFACTURER: Vertex Pharmaceuticals Incorporated

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Trikafta is a medication that combines three active ingredients: elexacaftor, tezacaftor, and ivacaftor. It is primarily used in the treatment of cystic fibrosis (CF), a genetic disorder that affects the lungs and other organs.